Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Perthera
McLean, Virginia, United Statesperthera.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Perthera offers an AI-powered precision oncology platform that integrates multiomic molecular data with patient history to generate ranked therapy options tailored to individual patients. Peer-reviewed studies show use of the Perthera Report leads to up to a 2.4-fold improvement in progression-free survival for patients whose providers follow its recommendations. The company’s technology has been validated in major journals such as The Lancet Oncology and The Oncologist. Over one-fifth of their patients enroll in clinical trials—six times the national average—and their solutions are used at more than 600 US hospitals/clinics.
- Therapeutic areas
- Oncology
- Modalities
- Multi-modal (multiomic) data integration for therapy selection (not a drug developer; focuses on data-driven recommendations)Integrates DNA, RNA, protein, and phosphoprotein molecular profilingChemo prediction algorithms for pancreatic cancer
- Industry
- Digital Health Medical Devices
02
Partnerships
Collaborates with leading NGS diagnostic providers including Tempus AI, Foundation Medicine, Caris Life Sciences, Guardant Healthalso works with biopharma companies and institutions such as the DOD Cancer Moonshot Program
Beyond the preview
Go deeper on Perthera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Perthera.